James Bauersmith

James Bauersmith

Direktör/Styrelseledamot på LANNETT COMPANY, INC.
Health Technology
Consumer Services
Health Services

Profil

James Bauersmith is currently the Director at Lannett Co., Inc. and the Vice President & Translational Sciences at UPMC Enterprises.
Previously, he worked as the Director at Akorn, Inc., the SVP & Head of Global Drug Portfolio Strategy at Fresenius SE & Co. KGaA, the Chief Strategy Officer & General Counsel at ByHeart, Inc., and the SVP Head of Corporate Development & Procurement at Amneal Pharmaceuticals, Inc. Mr. Bauersmith received his undergraduate degree from the University of Notre Dame in 1998 and his graduate degrees from Drexel University in 2005 and The Pennsylvania State University in 2001.

Aktiva positioner av James Bauersmith

FöretagPositionStart
LANNETT COMPANY, INC. Direktör/Styrelseledamot -
Företagsledare/Principal 2021-08-01

Tidigare kända positioner av James Bauersmith

FöretagPositionSlut
Generell Rådgivare 2021-10-01
AMNEAL PHARMACEUTICALS, INC. Företagsledare/Principal 2019-06-30
FRESENIUS SE & CO. KGAA Företagsledare/Principal 2018-05-31
AKORN, INC. Direktör/Styrelseledamot -
Se detaljerna i James Bauersmiths erfarenhet

James Bauersmiths utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

90

Första gradens relationer

9

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Non-Durables

Health Technology

  1. Börsen
  2. Insiders
  3. James Bauersmith